Amit Bhalla

This profile gathers the share dealings of Amit Bhalla in Navidea Biopharmaceuticals, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 4 May 2021 to 30 November 2022, the count stands at 18 filings.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 30 November 2022, the filings show a share grant in Navidea Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.